Massachusetts 2025-2026 Regular Session

Massachusetts House Bill H2200 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	1 of 1
2	2	HOUSE DOCKET, NO. 2183 FILED ON: 1/15/2025
3	3	HOUSE . . . . . . . . . . . . . . . No. 2200
4	4	The Commonwealth of Massachusetts
5	5	_________________
6	6	PRESENTED BY:
7	7	Marjorie C. Decker
8	8	_________________
9	9	To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
10	10	Court assembled:
11	11	The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:
12	12	An Act relative to the prescription monitoring program.
13	13	_______________
14	14	PETITION OF:
15	15	NAME:DISTRICT/ADDRESS :DATE ADDED:Marjorie C. Decker25th Middlesex1/15/2025 1 of 2
16	16	HOUSE DOCKET, NO. 2183 FILED ON: 1/15/2025
17	17	HOUSE . . . . . . . . . . . . . . . No. 2200
18	18	By Representative Decker of Cambridge, a petition (accompanied by bill, House, No. 2200) of
19	19	Marjorie C. Decker relative to the administration of opioid maintenance treatment in the
20	20	prescription monitoring program. Mental Health, Substance Use and Recovery.
21	21	The Commonwealth of Massachusetts
22	22	_______________
23	23	In the One Hundred and Ninety-Fourth General Court
24	24	(2025-2026)
25	25	_______________
26	26	An Act relative to the prescription monitoring program.
27	27	Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority
28	28	of the same, as follows:
29	29	1 SECTION 1. Section 24A of chapter 94C of the General Laws, as appearing in the 2022
30	30	2Official Edition, is hereby amended by inserting after subsection (c) the following subsection:-
31	31	3 (c½) The department shall establish, by rule or regulation, a process by which to include
32	32	4information about the administration of opioid maintenance treatment in the prescription
33	33	5monitoring program, when the inclusion of such information does not conflict with state or
34	34	6federal privacy rules. The purpose of this subsection shall be to ensure that licensed professionals
35	35	7authorized to prescribe controlled substances receive information, through utilization of the
36	36	8prescription monitoring program, about an individual patient’s participation in opioid
37	37	9maintenance treatment prior to issuing a new prescription for an opioid substance other than the
38	38	10substance used for opioid maintenance treatment.
39	39	11 SECTION 2. Section 18 of chapter 111E of the General Laws, as appearing in the 2022
40	40	12Official Edition, is hereby amended by inserting after subsection (a) the following subsection:- 2 of 2
41	41	13 (a½) For each facility that is an opioid treatment program, as defined under 42 CFR Part
42	42	148, the facility shall present to each individual entering treatment a form that allows the individual
43	43	15to consent to the release of information, through the prescription monitoring program, about the
44	44	16administration of opioid maintenance treatment at the facility. Said consent form shall be
45	45	17accompanied by information clearly explaining that such consent is not required but is
46	46	18encouraged to improve coordination of services; and by information on how the individual may
47	47	19complete and return the form to the facility or to the department of public health if they elect to
48	48	20give such consent. A record of the individual’s election relative to this form shall be maintained
49	49	21by the facility as part of the record of treatment required by this section. The same form and
50	50	22information shall be presented to the individual upon their discharge from the facility.